Massimo Pinzani

Q: What Schools Are Affiliated With Massimo Pinzani

Massimo Pinzani is affiliated with the following schools: Imperial College London, University College London, Case Western Reserve University, University of Florence, King's College London

Massimo Pinzani's AcademicInfluence.com Rankings

Massimo Pinzani

Engineering

#3311

World Rank

#4366

Historical Rank

Biomedical Engineering

#149

World Rank

#152

Historical Rank

engineering Degrees

Massimo Pinzani

Computer Science

#4306

World Rank

#4531

Historical Rank

Information Management

#34

World Rank

#35

Historical Rank

Computer Graphics

#92

World Rank

#95

Historical Rank

Algorithms

#135

World Rank

#137

Historical Rank

computer-science Degrees

Download Badge

Engineering
Computer Science

Massimo Pinzani's Degrees

PhD Biomedical Engineering University of Florence
Masters Biomedical Engineering University of Florence
Bachelors Biomedical Engineering University of Florence

Why Is Massimo Pinzani Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Massimo Pinzani's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). (2016) (1665)
Serum markers detect the presence of liver fibrosis: a cohort study. (2004) (1038)
Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. (2007) (791)
Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis (2007) (689)
Angiogenesis in liver disease. (2009) (523)
Hepatic fibrosis: Concept to treatment. (2015) (505)
Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. (1989) (474)
Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis (2010) (473)
Cytokine receptors and signaling in hepatic stellate cells. (2001) (449)
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. (2012) (442)
Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. (2013) (419)
Acute viral hepatitis increases liver stiffness values measured by transient elastography (2007) (408)
Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. (2000) (399)
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. (2019) (398)
Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. (1996) (382)
Baveno VII - Renewing consensus in portal hypertension. (2021) (363)
Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis (2008) (358)
StellaTUM: current consensus and discussion on pancreatic stellate cell research (2011) (351)
Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells. (1993) (343)
Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. (1992) (333)
Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation (2015) (328)
Liver fibrosis: from the bench to clinical targets. (2004) (325)
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells (2005) (321)
Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. (1998) (311)
Non invasive evaluation of portal hypertension using transient elastography. (2012) (307)
Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component. (2015) (296)
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C (2008) (291)
HNE interacts directly with JNK isoforms in human hepatic stellate cells. (1998) (290)
Neutrophil‐derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: Role of nitric oxide (1997) (286)
Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. (1996) (283)
Signal Transduction by the Chemokine Receptor CXCR3 (2001) (276)
Monocyte chemotactic protein‐1 as a chemoattractant for human hepatic stellate cells (1999) (267)
Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. (1994) (265)
Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. (2009) (256)
Fibrosis in chronic liver diseases: diagnosis and management. (2005) (249)
2018 Annual Report of the European Liver Transplant Registry (ELTR) – 50‐year evolution of liver transplantation (2018) (247)
Reversal of Liver Fibrosis (2009) (240)
Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. (1993) (234)
Signal transduction in hepatic stellate cells. (2008) (232)
Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. (1993) (217)
Keratin 19: a key role player in the invasion of human hepatocellular carcinomas (2013) (216)
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. (1999) (215)
PDGF and signal transduction in hepatic stellate cells. (2002) (213)
Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? (2010) (211)
Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells. (1997) (207)
Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. (2007) (204)
Malnutrition and sarcopenia predict post‐liver transplantation outcomes independently of the Model for End‐stage Liver Disease score (2016) (203)
Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography (2008) (195)
A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. (2005) (187)
Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells. (2009) (183)
Novel insights into the biology and physiology of the Ito cell. (1995) (181)
Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis. (1999) (181)
Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices. (2016) (178)
Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution (2013) (176)
Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study (2019) (164)
Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario. (2008) (162)
Extracellular signal‐regulated kinase activation differentially regulates platelet‐derived growth factor's actions in hepatic stellate cells, and is induced by In Vivo liver injury in the rat (1999) (160)
Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. (1991) (158)
Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. (2005) (148)
Hepatic stellate (ITO) cells: expanding roles for a liver-specific pericyte. (1995) (148)
Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans (2005) (148)
Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. (2006) (146)
Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts. (2009) (146)
The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. (2003) (144)
Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. (2005) (140)
gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis (2009) (138)
Expression of platelet‐derived growth factor in a model of acute liver injury (1994) (135)
Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process (2016) (131)
Binding of Hepatitis C Virus Envelope Protein E2 to CD81 Up-regulates Matrix Metalloproteinase-2 in Human Hepatic Stellate Cells* (2005) (129)
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study. (2014) (122)
Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. (1997) (122)
Non-invasive assessment of liver fibrosis: are we ready? (2010) (122)
4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. (2004) (121)
Adenosine monophosphate–activated protein kinase modulates the activated phenotype of hepatic stellate cells (2007) (120)
Long course and prognostic factors of virus-induced cirrhosis of the liver. (1997) (119)
Fibrogenesis & Tissue Repair (2009) (118)
Pathophysiology of Liver Fibrosis (2015) (118)
Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats. (1999) (117)
Enhanced liver fibrosis score predicts transplant‐free survival in primary sclerosing cholangitis (2015) (113)
Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma (2004) (113)
Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) (2009) (111)
Transcriptional Profiling Reveals Novel Markers of Liver Fibrogenesis (2006) (109)
Update on the pathophysiology of liver fibrosis (2010) (109)
American Journal of Physiology: Gastrointestinal and Liver Physiology American Journal of Physiology: Heart and Circulatory Physi- QlQgY American Journal of Physiology: Regulatory, Integrative and Comparative Physiology American Journal of Physiology: Renal, Fluid and Electrolyte (2003) (108)
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease. (2018) (108)
Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans. (2002) (108)
Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. (1995) (106)
MAIT cells are chronically activated in patients with autoimmune liver disease and promote profibrogenic hepatic stellate cell activation (2018) (106)
Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. (2011) (105)
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. (2000) (105)
CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis. (2018) (102)
Altered renal and platelet arachidonic acid metabolism in cirrhosis. (1986) (102)
Anti-fibrotic therapy: lost in translation? (2012) (100)
Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells. (1991) (99)
Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E. (1999) (99)
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice. (2007) (97)
Expression of the thrombin receptor in human liver: Up‐regulation during acute and chronic injury (1998) (96)
Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study. (1994) (95)
Increased Risk of Hepatocellular Carcinoma and Liver Cirrhosis in Vinyl Chloride Workers: Synergistic Effect of Occupational Exposure with Alcohol Intake (2004) (95)
Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents. (2017) (93)
Transforming growth factor‐β1 regulates platelet‐derived growth factor receptor β subunit in human liver fat‐storing cells (1995) (92)
Curcumin limits the fibrogenic evolution of experimental steatohepatitis (2010) (90)
A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis. (2011) (89)
Involvement of phosphatidylinositol 3‐kinase in the activation of extracellular signal‐regulated kinase by PDGF in hepatic stellate cells (1995) (88)
Altered platelet function in cirrhosis of the liver: Impairment of inositol lipid and arachidonic acid metabolism in response to agonists (1988) (87)
Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease (2013) (86)
Beyond scoring: a modern interpretation of disease progression in chronic liver disease (2013) (84)
Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells (2005) (84)
Regulation of macrophage colony-stimulating factor in liver fat-storing cells by peptide growth factors. (1992) (80)
Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension. (2016) (78)
Secretion of insulin-like growth factor-I and binding proteins by rat liver fat-storing cells: regulatory role of platelet-derived growth factor. (1990) (77)
Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. (1993) (77)
Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity (2017) (76)
Liver tissue engineering: From implantable tissue to whole organ engineering (2017) (76)
Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells. (1997) (75)
Agonist‐specific regulation of monocyte chemoattractant protein‐1 expression by cyclooxygenase metabolites in hepatic stellate cells (2001) (74)
Phosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cells. (2000) (73)
The biphasic nature of hypoxia‐induced directional migration of activated human hepatic stellate cells (2012) (73)
Arachidonic acid derivatives and renal function in liver cirrhosis. (1997) (73)
Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma. (2012) (72)
Rapid production of human liver scaffolds for functional tissue engineering by high shear stress oscillation-decellularization (2017) (72)
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease. (2020) (71)
Coagulation and fibrosis in chronic liver disease (2008) (70)
Epithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death? (2011) (69)
Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease. (2010) (68)
Optimization of Liver Decellularization Maintains Extracellular Matrix Micro-Architecture and Composition Predisposing to Effective Cell Seeding (2016) (65)
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. (1989) (65)
Progression of fibrosis in chronic liver diseases: time to tally the score. (2001) (65)
Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B. (2008) (64)
Tyrosine phosphorylation of focal adhesion kinase by PDGF is dependent on Ras in human hepatic stellate cells (2000) (63)
The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx. (1995) (63)
Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration. (2002) (63)
Hepatic stellate cells stimulate HCC cell migration via laminin-5 production. (2011) (62)
Induction of procollagen type I gene expression and synthesis in human hepatic stellate cells by 4-hydroxy-2,3-nonenal and other 4-hydroxy-2,3-alkenals is related to their molecular structure. (1996) (62)
Hepatic fibrosis 2022: Unmet needs and a blueprint for the future (2021) (61)
Interaction between 4-hydroxy-2,3-alkenals and the platelet-derived growth factor-beta receptor. Reduced tyrosine phosphorylation and downstream signaling in hepatic stellate cells. (2000) (61)
Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells. (1994) (61)
Endothelin-1 inhibits secretin-stimulated ductal secretion by interacting with ETA receptors on large cholangiocytes. (1998) (60)
Fibrosis and cirrhosis reversibility: clinical features and implications. (2008) (60)
Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis. (2005) (60)
Inhibition by pentoxifylline of extracellular signal‐regulated kinase activation by platelet‐derived growth factor in hepatic stellate cells (1996) (59)
Hepatic wound repair (2009) (58)
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis (2012) (57)
Induction of β-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture (1995) (54)
Contraction of human hepatic stellate cells activated in culture: a role for voltage-operated calcium channels. (1998) (53)
EXPRESSION OF PLATELET-DERIVED GROWTH-FACTOR RECEPTORS IN NORMAL AND DISEASED HUMAN KIDNEY (1994) (53)
Signal Transduction by the Chemokine Receptor CXCR3 ACTIVATION OF Ras/ERK, Src, AND PHOSPHATIDYLINOSITOL 3-KINASE/Akt CONTROLS CELL MIGRATION AND PROLIFERATION IN HUMAN VASCULAR PERICYTES* (2001) (53)
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells. (2003) (52)
Circulating growth hormone and insulin-like growth factor-I in nonalcoholic liver cirrhosis with or without superimposed hepatocarcinoma: evidence of an altered circadian rhythm. (1993) (51)
The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats. (1999) (51)
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C. (2013) (51)
Peptide growth factors stimulate macrophage colony-stimulating factor in murine stromal cells. (1991) (49)
Pathogenesis of biliary fibrosis. (2017) (49)
Phenotypical modulation of liver fat-storing cells by retinoids. Influence on unstimulated and growth factor-induced cell proliferation. (1992) (48)
Effect of pentoxifylline on the degradation of procollagen type I produced by human hepatic stellate cells in response to transforming growth factor‐β1 (1997) (47)
Biomarkers of intestinal fibrosis – one step towards clinical trials for stricturing inflammatory bowel disease (2016) (47)
Immediate effects of furosemide on renal hemodynamics in chronic liver disease with ascites. (1987) (44)
Mammalian target of rapamycin mediates the angiogenic effects of leptin in human hepatic stellate cells. (2011) (43)
Non-invasive evaluation of hepatic fibrosis: don’t count your chickens before they’re hatched (2006) (43)
Cell adhesion regulates platelet‐derived growth factor–induced MAP kinase and PI‐3 kinase activation in stellate cells (2002) (42)
Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells. (2004) (41)
ADMA correlates with portal pressure in patients with compensated cirrhosis (2007) (41)
Knockout of α6β1-integrin expression reverses the transformed phenotype of hepatocarcinoma cells (1998) (41)
Collagen proportionate area is an independent predictor of long‐term outcome in patients with non‐alcoholic fatty liver disease (2019) (41)
Referral pathways for patients with NAFLD based on non‐invasive fibrosis tests: Diagnostic accuracy and cost analysis (2019) (41)
Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies (2011) (41)
Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) (2009) (40)
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis (2017) (40)
Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo. (2013) (40)
Characterization and regulation of insulin‐like growth factor binding proteins in human hepatic stellate cells (1998) (40)
Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis. (2012) (39)
Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. (1994) (39)
Pathophysiology of Non-Alcoholic Steatohepatitis and Basis for Treatment (2011) (38)
The metabolic syndrome and chronic liver disease. (2014) (38)
Evaluating the association of serum ferritin and hepatic iron with disease severity in non‐alcoholic fatty liver disease (2019) (38)
Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance. (1987) (38)
Effects of captopril on renal function in patients with cirrhosis and ascites. (1987) (37)
Actions of platelet‐derived growth factor isoforms in mesangial cells (1994) (37)
Role of hepatic stellate cells in the pathogenesis of portal hypertension. (2002) (36)
Transforming growth factor-beta 1 regulates platelet-derived growth factor receptor beta subunit in human liver fat-storing cells. (1995) (36)
Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites. (1988) (35)
Undulin RNA and protein expression in normal and fibrotic human liver (1994) (35)
Digestive and Liver Disease (2011) (35)
Liver Stiffness, a Non-Invasive Marker of Liver Disease: A Core Study Group Report (2010) (35)
Ordered array of dendritic cells and CD8+ lymphocytes in portal infiltrates in chronic hepatitis C (2001) (35)
CHK2 overexpression and mislocalisation within mitotic structures enhances chromosomal instability and hepatocellular carcinoma progression (2017) (34)
Elastography for the non-invasive assessment of liver disease: limitations and future developments (2009) (33)
Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus‐related chronic liver disease (2007) (33)
Paediatric non-alcoholic fatty liver disease (2010) (32)
Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: the missing tool? (2009) (32)
Welcome to Fibrogenesis & Tissue Repair (2008) (31)
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy (2020) (31)
Cirrhotic Human Liver Extracellular Matrix 3D Scaffolds Promote Smad-Dependent TGF-β1 Epithelial Mesenchymal Transition (2019) (30)
Hepatic stellate cell nomenclature. (1996) (30)
Liver Fibrosis in the Post-HCV Era (2015) (29)
Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades (2018) (29)
MARCKS is a downstream effector in platelet-derived growth factor-induced cell motility in activated human hepatic stellate cells. (2008) (28)
Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling (2017) (28)
Integrin‐mediated stimulation of monocyte chemotactic protein‐1 expression (1997) (28)
Challenges in the Pathophysiology, Diagnosis and Management of Intestinal Fibrosis in Inflammatory Bowel Disease. (2019) (28)
Decoupling competing surface binding kinetics and reconfiguration of receptor footprint for ultrasensitive stress assays. (2015) (28)
Recurrent HCV after liver transplantation—mechanisms, assessment and therapy (2014) (28)
Serological markers of extracellular matrix remodeling predict transplant‐free survival in primary sclerosing cholangitis (2018) (27)
Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease. (2009) (26)
Nuclear localization of TRK-A in liver cells. (2008) (26)
Defining the Minimum Acceptable Diagnostic Accuracy of Noninvasive Fibrosis Testing in Cirrhosis: A Decision Analytic Modeling Study (2019) (26)
Non invasive diagnosis of portal hypertension in cirrhotic patients. (2008) (26)
Evaluation of intracellular signalling pathways in response to insulin-like growth factor I in apoptotic-resistant activated human hepatic stellate cells (2009) (25)
Knockout of alpha6 beta1-integrin expression reverses the transformed phenotype of hepatocarcinoma cells. (1998) (25)
MARCKS actin-binding capacity mediates actin filament assembly during mitosis in human hepatic stellate cells. (2012) (24)
Non‐invasive assessment of liver fibrosis in patients with HBV‐related chronic liver disease undergoing antiviral treatment: A preliminary study (2017) (23)
The incidence, etiologies, outcomes, and predictors of mortality of acute liver failure in Thailand: a population-base study (2019) (23)
Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma (2022) (22)
Pancreatic stellate cells: new kids* become mature (2005) (22)
Liver failure complicating segmental hepatic ischaemia induced by a PTFE-coated TIPS stent (2009) (21)
Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver disease (2009) (21)
Development and Regression of Cirrhosis (2016) (21)
Fibroblasts and extracellular matrix: Targeting and therapeutic tools in fibrosis and cancer. (2017) (20)
Amyloid persistence in decellularized liver: biochemical and histopathological characterization (2015) (20)
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis (2017) (19)
The ELF panel: a new crystal ball in hepatology? (2010) (19)
Collagen proportionate area predicts clinical outcomes in patients with alcohol‐related liver disease (2020) (18)
Detection of cytochrome P4503A (CYP3A) in human hepatic stellate cells. (1997) (18)
A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damage (2020) (18)
Transaminase abnormalities and adaptations of the liver lobule manifest at specific cut-offs of steatosis (2017) (17)
Decellularized Human Gut as a Natural 3D Platform for Research in Intestinal Fibrosis. (2019) (17)
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients. (2021) (17)
Neuron-derived orphan receptor 1 promotes proliferation of quiescent hepatocytes. (2013) (16)
Thromboxane-receptor blockade increases water diuresis in cirrhotic patients with ascites. (1992) (16)
Defective spleen function in autoimmune gastrointestinal disorders (2019) (16)
Intrarenal thromboxane A2 generation reduces the furosemide-induced sodium and water diuresis in cirrhosis with ascites. (1988) (15)
Effects of repeated atrial natriuretic peptide bolus injections in cirrhotic patients with refractory ascites. (2008) (14)
Modulation of hepatic fibrogenesis by antioxidants. (1993) (13)
Pathophysiology of Organ and Tissue Fibrosis. (2019) (13)
Sodium Retention in Cirrhosis: Aspects of Pathophysiology and Treatment1 (1986) (13)
Increasing the accuracy of proteomic typing by decellularisation of amyloid tissue biopsies (2017) (13)
The stratification of cirrhosis (2020) (13)
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells. (2019) (12)
Multiparametric ultrasound in liver diseases: an overview for the practising clinician (2019) (12)
Reactive gamma‐ketoaldehydes as novel activators of hepatic stellate cells in vitro (2015) (12)
A Fragment of Collagen Type VI alpha-3 chain is Elevated in Serum from Patients with Gastrointestinal Disorders (2020) (12)
Platelet‐derived growth factor receptor expression in hepatic stellate cells: How too much of a good thing can be bad (1995) (12)
The Hepatic Stellate Cell (2008) (12)
Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH (2020) (12)
The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells. (2017) (12)
Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression (2019) (11)
Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis (2019) (11)
Hepatic regenerative medicine. (2015) (11)
Treatment of Ascites in Cirrhosis (1996) (11)
Liver fibrosis (2004) (11)
New kids on the block: pancreatic stellate cells enter the fibrogenesis world (1999) (11)
Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis (2019) (11)
Establishing Reliability Criteria for Liver ElastPQ Shear Wave Elastography (ElastPQ-SWE): Comparison Between 10, 5 and 3 Measurements (2018) (10)
Anatomy and Vascular Biology of the Cells in the Portal Circulation (2005) (10)
gp120 induces directional migration of human hepatic stellate cells: A link between HIV infection and liver fibrogenesis (2008) (10)
Unraveling the spider web of hepatic stellate cell apoptosis. (2009) (10)
Exploring beyond cirrhosis (2012) (10)
Comparison and correlation of fibrosis stage assessment by collagen proportionate area (CPA) and the ELF panel in patients with chronic liver disease. (2019) (10)
Hexa Histidine–Tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen Species (2021) (10)
Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis. (1987) (9)
Therapies for hepatic fibrosis: real hope or just academic exercise? (2004) (9)
Decellularized Human Liver as a Natural 3D Scaffold for Organ Engineering and 3D-Disease Modeling (2014) (9)
Alcoholic and non-alcoholic fatty liver in adolescents: a worrisome convergence. (2011) (9)
TGF-β-driven reduction of cytoglobin leads to oxidative DNA damage in stellate cells during non-alcoholic steatohepatitis. (2020) (9)
Intrabiliary metastasis from rectal cancer mimicking peripheral papillary-type cholangiocarcinoma. (2004) (9)
Optimization and Validation of a Novel Three-Dimensional Co-Culture System in Decellularized Human Liver Scaffold for the Study of Liver Fibrosis and Cancer (2019) (9)
The adenosine monophosphate–activated protein kinase—vacuolar adenosine triphosphatase–pH axis: A key regulator of the profibrogenic phenotype of human hepatic stellate cells (2018) (8)
Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion. (1983) (8)
Reply to "Points to be considered when using transient elastography for diagnosis of portal hypertension according to the Baveno's VI consensus". (2015) (7)
[Effects of alpha lipoic acid and pirfenidone on liver cells antioxidant modulation against oxidative damage]. (2014) (7)
Foreword to liver fibrosis. (2011) (7)
The AMPK-v-ATPase-pH axis : a key regulator of the pro-fibrogenic phenotype of human hepatic stellate cells (2018) (7)
Small diameter H-graft porta-caval shunt performed at different stages of liver disease. (2004) (7)
Noninvasive methods for the assessment of liver fibrosis: A window open on the future? (2011) (6)
Evidence for alpha 1-adrenoreceptor hyperresponsiveness in hypotensive cirrhotic patients with ascites. (1991) (6)
Ectopic expression of the calcium‐binding protein parvalbumin in mouse liver endothelial cells (1997) (6)
Dysregulated Intrahepatic CD4+ T-Cell Activation Drives Liver Inflammation in Ileitis-Prone SAMP1/YitFc Mice (2015) (6)
Erratum to “Liver fibrosis: from the bench to clinical targets” [Dig. Liver Dis. 36 (2004) 231–242] (2004) (6)
Fibrosis in the GI Tract: Pathophysiology, Diagnosis and Treatment Options (2010) (6)
Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease (2020) (6)
Nuclear localization of the nerve growth factor (NGF) receptor, TRK-A in liver cells (2003) (5)
Pathogenetic Mechanisms in Renal Functional Impairment in Cirrhotics1 (1984) (5)
Monocyte chemotactic protein-1 stimulates hepatic stellate cell chemotaxis (1998) (5)
The holy grail of a biomarker for “liver function” (2016) (5)
Diuretic and natriuretic effects of long-term albumin infusion in patients with cirrhosis and ascites: a randomised controlled study (2001) (5)
Silybin is a direct antifibrogenic and antiinflammatory agent: Cellular and molecular mechanisms (2008) (5)
Elevated ectodomain of type 23 collagen is a novel biomarker of the intestinal epithelium to monitor disease activity in ulcerative colitis and Crohn's disease (2020) (4)
Assessment of clinically significant portal hypertension by two‐dimensional shear wave elastography (2022) (4)
Pathogenetic factors of renal dysfunction in chronic liver disease (1989) (4)
Hepatic Fibrosis: A Global Clinical Problem (2015) (4)
Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH) (2021) (4)
AICAR and Compound C negatively modulate HCC-induced primary human hepatic stellate cell activation in vitro. (2021) (4)
Collagen proportionate area correlates with histological stage and predicts clinical events in primary sclerosing cholangitis (2021) (4)
Asian Pacific Association for Study of the Liver (APASL) (2003) (4)
Comparison of ElastPQ Shear-wave Elastography (ElastPQ-SWE) and FibroScan Transient Elastography (F-TE) for liver fibrosis staging in patients with NAFLD (2018) (4)
Marra F, DeFranco R & Grappone C et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: Correlation with monocyte infiltration. Am J Pathol152: 423-430 (1998) (4)
1280 Leptin receptors on human hepatic stellate cells mediate the expression of pro-inflammatory and pro-angiogenic cytokines (2003) (4)
Pathogenesis and Evolution of Liver Fibrosis: Cirrhosis or Cirrhoses? (2015) (3)
Hemodynamic derangement and cardiac dysfunction in cirrhosis. (2004) (3)
1368 FURTHER VALIDATION OF TERMINAL PEPTIDE OF PROCOLLAGEN III (PIIINP) FOR THE DETECTION AND ASSESSMENT OF NONALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (2013) (3)
Histological sub‐classification of cirrhosis using collagen proportionate area in patients with chronic hepatitis C (2021) (3)
Activated human hepatic stellate cells are resistant to classic pro-apoptotic stimuli (2003) (3)
Refractory ascites: definition, pathogenesis and treatment. (1993) (3)
Expression and localization of tetraspanin molecules in human hepatic stellate cells and their role in cell motility and wound-healing migration (2001) (3)
Regenerative hepatology: In the quest for a modern prometheus? (2020) (3)
IGF-I is a survival factor for human hepatic stellate cells (HSC): involvement of PI 3-K and C-Akt (2001) (3)
Human hepatic stellate cells (HSC) promote scattering and invasion of colon cancer cells (2002) (3)
Cross-talk between phosphatidylinositol 3-kinase (PI3-K) and the NA+/H+ exchanger in hepatic stellate cells (HSC): effect of canrenone (2001) (3)
Purification of PGE2 in the urine of cirrhotic patients: comparison of three chromatographic techniques. (1988) (3)
The Baveno VI Guidelines: Can We Confidently Identify Low Risk Cirrhotic Patients not Requiring Endoscopic Surveillance for Varices? (2016) (2)
Serological Biomarkers of Extracellular Matrix Remodeling Predict Transplant-Free Survival in Primary Sclerosing Cholangitis Patients (2016) (2)
1275 Presence and function of myristoylated alanine-rich protein kinase C substrate () in activated human liver hepatic stellate cells () (2003) (2)
Liver stiffness measurement (LSM) is able to predict severe portal hypertension in patients with HCV-related advanced chronic liver disease (2007) (2)
Referral pathways for patients with non-alcoholic fatty liver disease based on non-invasive fibrosis tests: diagnostic accuracy and cost analysis of a two-tier approach (2017) (2)
Non-invasive systems for staging compensated cirrhosis (2010) (2)
Point shear wave elastography (ElastPQ) is a reliable non-invasive tool for the diagnosis and characterisation of portal hypertension (2017) (2)
count your chickens before they're hatched Non-invasive evaluation of hepatic fibrosis: don't (2006) (2)
Modulation of hepatic fibrogenesis by antioxidants (1995) (2)
Renal Functional Impairment in Cirrhosis (1987) (2)
Elastic fibres in alcoholic liver disease (2020) (2)
Validation of the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease: an individual patient meta-analysis (2017) (2)
321 High levels of BCL-2, C-AKT and TRK-A in activated human hepatic stellate cells: Possible mechanisms for survival to apoptosis induction (2004) (2)
Reversible factors in portal hypertension (2004) (2)
Development of human liver extracellular matrix hydrogel for three dimensional cell culture and cell transplantation (2016) (2)
The hepatorenal syndrome (2004) (2)
Surrogate endpoints for clinical trials in non-alcoholic steatohepatitis. (2017) (2)
Collagen proportion area is an independent predictor of longterm outcome in patients with non-alcoholic fatty liver disease (2017) (2)
Expression of platelet-derived growth factor (PDGF) and its $alpha; and $beta; receptor subunits in normal and cirrhotic liver (1993) (2)
Response to letter by R. Mookerjee and R. Jalan (2007) (1)
Profibrogenic Actions of Hepatic Stellate Cells: Major Intracellular Signaling Pathways (2003) (1)
History and Early Work (2015) (1)
Three-dimensional bioactive human liver acellular scaffold with preserved architecture and biomechanical properties (2015) (1)
1036 THE ADIPOKINE CHEMERIN AS A NOVEL FACTOR REGULATING THE FIBROGENIC PHENOTYPE OF HUMAN HEPATIC STELLATE CELLS (2011) (1)
Essential role for Toll-like receptor 9 in the pathogenesis of liver inflammation in a murine model of Crohn’s disease-like ileitis (P3147) (2013) (1)
Upregulated expression of human thrombin receptor in acute and chronic liver disease (1995) (1)
PTH-119 Differences between radiology and histopathology: are we judging wrong? should we lower alpha-fetoprotein cut-off in the selection criteria? (2015) (1)
When and How to Perform Surveillance (2016) (1)
Acute effect of furosemide on renal kallikrein and prostaglandin systems in mild to moderate essential hypertension. (1987) (1)
Consensus Statements: Session 1—Screening and Surveillance (2016) (1)
Handling of Activation Status of Human Hepatic Stellate Cells by Low-Molecular-Weight FGF2 via the Induction of Cytoglobin (2016) (1)
Mo1822 – Elevated Ectodomain of Type 23 Collagen is a Novel Biomarker of the Intestinal Epithelium to Monitor Disease Activity in Ulcerative Colitis and in Crohns Disease (2019) (1)
Investigating the effect of adrenomedullin on hepatic NF-kB activation by 2D and 3D hepatic cell cultures (2018) (1)
Engineering Healthy And Cirrhotic Human Liver Matrix: A New 3D Platform For Investigating Liver Cirrhosis And HCC (2015) (1)
Tissue-Specific Human Extracellular Matrix Scaffolds Promote Pancreatic Tumour Progression and Chemotherapy Resistance (2022) (1)
Expanding the severity range of polytetrafluoroethylene‐related hepatic outflow occlusion (2009) (1)
30 THE CHEMOKINE RECEPTOR CCR5 MEDIATES THE PROFIBROGENIC ACTIONS OF THE HIV ENVELOPE PROTEIN GP120 IN HUMAN HEPATIC STELLATE CELLS (2009) (1)
CLINICAL—LIVER, PANCREAS, AND BILIARY TRACT Performance of ELF Serum Markers in Predicting Fibrosis Stage in Pediatric Non-Alcoholic Fatty Liver Disease (2009) (1)
4-Hydroxynonenal selectively up-regulates timp-1 gene expression inhuman hepatic stellate cells (2002) (1)
P0437 : Reactive gamma-ketoaldehydes as novel activators of hepatic stellate cells in vitro (2015) (1)
Risk factors for hepatocellular carcinoma in a large cohort of patients affected by primary sclerosing cholangitis (2018) (1)
762 TRANSIENT ELASTOGRAPHY (TE) IS MORE EFFECTIVE FOR THE IDENTIFICATION OF HCV PATIENTS WITH ADVANCED (F3-F4) RATHER THAN SIGNIFICANT (F2-F4) LIVER FIBROSIS (2008) (1)
SAT-322-Comparison of point shear wave elastography (ElastPQ-pSWE) and FibroScan Transient Elastography (F-TE) for liver fibrosis staging in patients with NAFLD (2019) (1)
694 Long term exposure to low levels of bacterial derived cell wall products activates murine hepatic stellate cells (2003) (1)
through Tumor-Stromal Interactions A Secreted Form of ADAM 9 Promotes Carcinoma Invasion (2005) (1)
484 INTRACELLULAR REDOX CHANGES AND C-JUN N-TERMINAL KINASE ACTIVATION AS CRUCIAL EVENTS IN CYTOKINE-INDUCED CHEMOTAXIS OF HUMAN ACTIVATED HEPATIC STELLATE CELLS (2008) (1)
Endothelin-1 inhibits secretin-stimulated ductal secretion by interacting with ETA receptors on large cholangiocytes. (1998) (1)
Migration of human activated hepatic stellate cells induced by superoxide anion: a Ras/Erk – dependent event that does not affect proliferation (2005) (1)
Stellate Cells and the Microcirculation (2011) (1)
Resistin as an Intrahepatic Cytokine (2010) (1)
Role of deregulation of the APC-WNT-beta catenin signaling and microsatellite instability in hepatic carcinogenesis. Preliminary results in a series of 20 sporadic hepatoblastomas and 11 non virus-related hepatocellular carcinomas (2002) (1)
A Serological Biomarker of Laminin Gamma 1 Chain Degradation Reflects Altered Basement Membrane Remodeling in Crohn’s Disease and DSS Colitis (2021) (1)
Intestinal and hepatic fibrosis: how are they similar? (2019) (1)
Collagen proportionate área is an independent predictor of long term outcome in patients with alcoholic liver disease (2018) (1)
OTU-12 Spleen stiffness has a good performance in predicting clinically significant portal hypertension in PSC (2019) (1)
Extracellular Matrix Scaffolds Obtained from Human Normal or Cirrhotic Liver as Novel Platforms to Investigate The Biology of Liver Cancer Cells. (2016) (1)
285 HYPOXIA – INDUCED MIGRATION OF HEPATIC STELLATE CELLS AND BONE MARROW – DERIVED MESENCHYMAL STEM CELLS INVOLVES COMMON REDOX MECHANISMS (2009) (1)
Progression of chronic hepatitis: from inflammation to fibrosis (2007) (1)
Cytokine – induced migration of human hepatic stellate cells requires activation of c-jun n-terminal kinase and intracellular generation of reactive oxygen species (2007) (1)
[Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications]. (1996) (1)
CXCR3-binding chemokines as survival factors in human hepatic stellate cells (2001) (1)
Nuclear localization of TRKA in liver cells (2007) (1)
P8 3D BIOLOGICAL SCAFFOLDS OBTAINED FROM DISCARDED HUMAN LIVERS AS A PLATFORM FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2014) (1)
T-26 The myostatin system is expressed in the liver and its activation mediates profibrogenic actions via c-Jun N-terminal kinase (2013) (1)
1047 KERATIN 19: A KEY ROLE PLAYER IN THE INVASION OF HUMAN HEPATOCELLULAR CARCINOMAS (2013) (1)
Comparison of point-shear wave elastography (ElastPQ) and FibroScan for liver fibrosis staging in patients with NAFLD. (2022) (1)
[346] EXPRESSION OF BILE ACID TRANSPORT AND DETOXIFICATION SYSTEMS AND THEIR REGULATORY NUCLEAR RECEPTORS IN HUMAN HEPATIC STELLATE CELLS (2007) (1)
4-hydroxy-2,3-alkenals impair tyrosine phosphorylation and downstream signaling of the PDGF-β receptor in human hepatic stellate cells (2000) (1)
Identification of FGF2 as a cytoglobin regulatory factor leading to the deactivation of human hepatic stellate cells (2015) (0)
Hepatic differentiationof human induced pluripotent stem cells (iPSC) using 3D human liverextracellular matrix hydrogel (2018) (0)
Common signalling and redox sensitive events regulate migration and chemotaxis of bone marrow – derived mesenchymal stem cells and hepatic stellate cells. (2009) (0)
P0443 : Hyperammonemia activates human hepatic stellate cells and is a target for treatment of portal hypertension (2015) (0)
Angiogenesis in liver disease q (2009) (0)
462 AMP-ACTIVATED PROTEIN KINASE (AMPK) REGULATES THE ACTIVATION PROCESS OF HEPATIC STELLATE CELLS (2008) (0)
[713] CURCUMIN INHIBITS THE FIBROGENIC PROGRESSION OF MURINE STEATOHEPATITIS (2007) (0)
Primary Biliary Cholangitis (2020) (0)
P620 THE AMPK-RELATED KINASE, Nuak2 IS MODULATED BY THE ACTIVATION PROCESS AND REGULATES MOTILITY OF HEPATIC STELLATE CELLS (HSC) (2014) (0)
Non-invasive Assessment of Fibrosis and Cirrhosis (2018) (0)
P095 Newly discovered gut matrikines from Crohn’s disease intestinal tissue induce cell proliferation, activation and inflammatory response in intestinal myofibroblasts in vitro (2023) (0)
Primary human HSC cell phenotype is differently regulated by pro-fibrogenic and pro-inflammatory stimuli in cirrhotic and healthy human liver 3D ECM scaffolds (2018) (0)
P303 Serological assessment of type XVI collagen reflects intestinal strictures in Crohn’s disease patients (2018) (0)
Vasoactive factors in decompensated cirrhosis. Effect of acute plasma expansion. (1984) (0)
Non-invasive assessment of liver fibrosis by point share wave elastography in primary biliary cholangitis: comparison with fibroscan® and fibrosis scores (2017) (0)
868 STROMAL-DERIVED FACTOR-1 (SDF-1) – CXCR4 AXIS HAS AN IMPORTANT ROLE ON THE INTERACTION OF HUMAN HEPATIC STELLATE CELLS (HHSC) AND CC CELL LINES (2010) (0)
AMP-activated protein kinase (AMPK) regulates the activation process of hepatic stellate cells (2008) (0)
Common signalling events regulate migration and chemotaxis of hepatic stellate cells and bone marrow-derived mesenchymal stem cells (2008) (0)
Diagnostic performance of point share wave elastography (pSWE) in comparison with transient elastography performed by Fibroscan® (TE) and non-invasive scores of fibrosis in primary biliary cirrhosis (PBC) (2016) (0)
AMP-activated protein kinase (AMPK) blocks the effects of PDGF by PI3K-independent signals and is downregulated during in vivo activation of hepatic stellate cells (2007) (0)
The paracrine effect of visceraladipose tissue obtained at bariatric surgery on primary human hepatic stellatecells grown in human 3D healthy liver scaffolds (2018) (0)
The Assessment of Portal Hypertension (2021) (0)
THE AMPK RELATED KINASE NUAK2 INTERACTS WITH TGF-BETA AND REGULATES THE ACTIVATION PROCESS OF HEPATIC STELLATE CELLS (HSC) (2015) (0)
F8-3 The role of Ito cells in hepatic fibrosis and portal hypertension (1995) (0)
P1192 : Azathioprine, steroids and the presence of inflammatory bowel disease before liver transplantation influence transplant free survival in primary sclerosing cholangitis (2015) (0)
Identification and function of MARCKS in human hepatic stellate cells (HHSC) (2003) (0)
EASL recognition awardee 2012: Professor Scott L. Friedman. (2012) (0)
288 A NEW FUNCTIONAL ROLE FOR NUCLEAR MARCKS DURING CELL CYCLE IN HUMAN HEPATIC STELLATE CELLS (2009) (0)
NGF and Trk-A as a novel autocrine loop in the early stages of hepatic stellate cell (HSC) activation (2002) (0)
Pirfenidone improves NASH features induced by high fat/carbohydrate diet in mice (2014) (0)
The vacuolar adenosine tri-phosphatase (v-ATPase) proton pump as therapeutic target in human activated HSC (2017) (0)
P1302 THE OPTIMAL IMMUNOSUPPRESSION REGIMEN FOR DELAYING FIBROSIS PROGRESSION IN HCV AFTER LIVER TRANSPLANTATION (2014) (0)
Albumin and stellate cell activation: wonders will never cease! (2009) (0)
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis (2017) (0)
Characterization of bioengineered liver constructs using hepatoblast organoids (HBOs) and human liver extracellular matrix (ECM) 3D-platforms (2022) (0)
Diagnosis of liver fibrosis with the help of serum marker algorithms (2001) (0)
HEPATIC STELLATE CELLS: 332 (2004) (0)
P0283 : Adenosine monophosphate activated kinase (AMPK) in cancer and human hepatic stellate cell crosstalk (2015) (0)
Cirrhotic extracellular matrix affects Hic-5 expression in primary human hepatic stellate cells (2020) (0)
Safety and current status of blood transfusion in China (2010) (0)
Reply: (2008) (0)
The Cellular and Molecular Basis of Liver Fibrogenesis (1996) (0)
OC.02.2 HUMAN NEUTROPHIL ELASTASE CONTRIBUTES TO LOSS OF FUNCTION OF INFLIXIMAB IN ULCERATIVE COLITIS (2016) (0)
The role of hepatic stellate cells/myofibroblasts (2004) (0)
MITOTIC CHECKPOINT CHK2 UPREGULATION IS LINKED TO CHROMOSOMAL INSTABILITY IN HUMAN HEPATOCELLULAR CARCINOMA (2016) (0)
[210] EVIDENCE FOR A PATHOGENETIC ROLE OF ASYMMETRIC DIMETHYLARGININE (ADMA) IN CIRRHOTIC PORTAL HYPERTENSION (2007) (0)
Early redox-sensitive activation of JNK isoforms switch on hypoxia-induced migration of human hepatic stellate cells (2008) (0)
H2O2 and 4-hydroxy-2,3-alkenals affect basal- and PDGF-dependent proliferation in human hepatic stellate cells (HSC) (1998) (0)
3D bio-printing ofhuman hepatic tissue using human liver extracellular matrix as tissue-specificbioink (2018) (0)
Liver Stiffness Measured by Acoustic Radiation Force Impulse Quantification in Primary Sclerosing Cholangitis: A Comparison with Transient Elastography Performed by Fibroscan® and Other Non-Invasive Tests (2016) (0)
[78] COMPARISON BETWEEN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND LIVER STIFFNESS MEASUREMENT (LSM) IN PATIENTS WITH HCV-RELATED FIBROSIS/CIRRHOSIS (2007) (0)
P0257 : Lipid peroxides stimulate interleukin-6 formation from stellate cells by an oxidative stress-dependent mechanism (2015) (0)
[319] AMP-ACTIVATED PROTEIN KINASE (AMPK) BLOCKS THE EFFECTS OF PDGF BY PI3K-INDEPENDENT SIGNALS AND IS DOWNREGULATED DURING IN VIVO ACTIVATION OF HEPATIC STELLATE CELLS (2007) (0)
289 THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS (2009) (0)
Extracellular matrix turnover is regulated in 3D disease-specific human liver scaffolds engineered with human hepatic stellate cells (2017) (0)
A novel CCL24 blocking monoclonal antibody ameliorates liver injury in experimental models of cholestasis (2018) (0)
345 BcI-2 overexpression in human activated hepatic stellate cells: A survival and pro-fibrogenic mechanism: 346 Abstract withdrawn (2006) (0)
SAT-431-Spleen stiffness measurement with ElastPQ point shear wave elastography has an excellent performance in predicting the presence of clinically significant portal hypertension in primary biliary cholangitis (2019) (0)
Regenerating hepatocytes are both source and target of fractalkine(FKN) during fulminant hepatitis (2000) (0)
Analysis of PNPLA3 SNP variants in human hepatic stellate cells in 3D human liver extracellular matrix scaffolds reveals key PNPLA3-dependent pro-fibrogenic features (2020) (0)
Effects of nitric oxide (NO)-donors on activated human hepatic stellate cells (HSC): cellular basis for the treatment of portal hypertension (1998) (0)
Azathioprine Immunosuppression Is Protective Against Recurrence of Primary Biliary Cirrhosis after Liver Transplantation. (2014) (0)
Hypoxia - and VEGF – dependent migration and chemotaxis of activated hepatic stellate cells operates through Flk-1 (2006) (0)
[Rheumatic diseases and liver involvement]. (1981) (0)
Silencing of Bcl-2 by specific siRNA sensitizes human-activated hepatic stellate cells to TNF – induced apoptosis (2006) (0)
T.N.41 INTRACELLULAR GENERATION OF REACTIVE OXYGEN SPECIES AS A CRUCIAL REQUIREMENT FOR DIRECTIONAL MIGRATION OF HEPATIC PRO-FIBROGENIC CELLS (2010) (0)
Professor Paolo Gentilini, MD (1930–2015) (2015) (0)
The clinical utility of non-invasive tests in cirrhosis: results of decision analysis modelling (2017) (0)
Cholangiocarcinoma (CCA) express chemokine receptor CXCR7: Important role of CXCR7 in mediating CXCL12 induced CCA cells chemotaxis and survival (2014) (0)
Simple Non Invasive Fibrosis Scores Predict Long Term Mortality in Patients with Non Alcoholic Fatty Liver Disease (2016) (0)
333 Rat hepatic stellate cells express the intermediate filament anchor protein synemin (2004) (0)
OC.14.1: Development of Decellularised Human GUT as a Natural 3D-Platform for Intestinal Bioengineering (2017) (0)
The mammalian target of rapamycin mediates the angiogenic and chemotactic effects of leptin in human hepatic stellate cells. (2010) (0)
Expression of the chemokine CCL21 during chronic hepatitis C: potential role in inflammation and fibrosis (2002) (0)
P0178 : Sarcopenia and malnutrition predict early post-liver transplantation outcomes independently of the meld score: implications for organ allocation (2015) (0)
1129 SERPIN-B3 AS A PRO-FIBROGENIC MEDIATOR CONTRIBUTING TO CHRONIC LIVER DISEASE PROGRESSION (2013) (0)
PWE-096 Non-invasive assessment of disease severity in primary sclerosing cholangitis (psc): clinical scores, transient elastography (te) and the enhanced liver fibrosis (elf) test (2015) (0)
Collagen proportionate area is an independent predictor of short and long-term survival in patients with alcoholic hepatitis (2018) (0)
THU-022-CM-101-a Novel anti CCL24 monoclonal antibody reduces cholangiocytes proliferation in experimental cholestasis models (2019) (0)
Faculty Opinions recommendation of Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin. (2007) (0)
PTH-134 Reduced calcineurin inhibitor exposure early after liver transplantation protects against renal dysfunction independently of the use of basiliximab induction therapy (2015) (0)
Faculty Opinions recommendation of Cholestasis protects the liver from ischaemic injury and post-ischaemic inflammation in the mouse. (2007) (0)
Ultrastructural features and distribution of dendritic cells (DC) in portal infiltrates of patients with HCV-related chronic active hepatitis (CAH) (2000) (0)
4-Hydroxynonenal elicits in human hepatic stellate cells a c-jun/JNK2/AP-1 signalling pathway preceeded by early generation of nuclear adducts. (1997) (0)
EASL International Recognition Award Recipient 2017: Professor Kenjiro Wake. (2017) (0)
PDGF acivation of map kinase (MAP-K) requires focal adhesionkinase/C-SRC complex formation in human hepatic stellate cells (HSC) (2000) (0)
Role of gamma-ketoaldehydes as novel mediators of experimental fibrogenesis and stellate cells activation (2014) (0)
16 Identification of a cross talk between the PDGF-beta receptor signalling pathway and the myristoylated alanine-rich PKC substrate (MARCKS) protein in activated human hepatic stellate cells (2004) (0)
What is new in the liver sinusoids? meeting report, 16th International Symposium on Cells of the Hepatic Sinusoid (ISCHS) (2011) (0)
The CXCL12/CXCR7 system mediates migration and survival of cholangiocarcinoma (CCA) cells through interaction with CXCR4 and β-arrestin-2 (2016) (0)
P0281 : Decellularised human liver as a natural scaffold for 3D-disease modelling (2015) (0)
P121 Cost-Effectiveness of Alpha-1 Antitrypsin (A1AT) Deficiency Case-Finding in Secondary Care (2013) (0)
Binding of hepatitis C virus envelope protein E2 to CD81 induces the expression of pro-MMP2 in human hepatic stellate cells (2001) (0)
OC-03 SERPIN-B3 as a pro-fibrogenic mediator contributing to chronic liver disease progression (2013) (0)
How to evaluate portal hypertension Is HVPG measurement a relevant gold standard for portal hypertension assessment ? (2012) (0)
Calcium-dependent activation of NF-kappa B by the adipokine resistin in hepatic stellate cells (2005) (0)
P0081 : Reduced calcineurin inhibitor exposure early after liver transplantation protects against renal dysfunction independently of the use of basiliximab induction therapy (2015) (0)
Reactive gamma-ketoaldehydes induce a proinflammatory phenotype, oxidative stress, and activation of autophagy in primary human hepatic stellate cells (2015) (0)
Biliary Tract Cancer with or without Primary Sclerosing Cholangitis is Associated with a Raised Enhanced Liver Fibrosis Test Result Compared with PSC Alone (2016) (0)
335 Type II phosphatidylinositol 4-kinase beta expression reverts epidermal growth factors-stimulated invasiveness of hepatocarcinoma cells (2004) (0)
Effects of endothelin isopeptides in cultured human hepatic stellate cells (HSC) (1995) (0)
Reply to: "The BAVENO VI criteria to identify patients not requiring endoscopic surveillance for esophageal varices - Should We use it?" (2017) (0)
Aspecific ECM composition regulates Smad dependent – TGFbeta1-induced EMT response in HepG2 cells engineered in cirrhotic and healthyliver 3D scaffolds (2018) (0)
THU-337-Cardiovascular risk factors and fibrosis severity in NAFLD: is there a link? (2019) (0)
ElastPQ shear-wave elastography compared to fibroscan transient elastography for fibrosis staging in patients with NAFLD (2017) (0)
970 OCCURRENCE AND CLINICOPATHOLOGICAL RELEVANCE OF PROGNOSTIC MARKERS IN HEPATOCELLULAR CARCINOMA (2011) (0)
Hepatology 2001. (2001) (0)
Obesity alters the partitioning of glycerol metabolism pathways in NAFLD (2022) (0)
A new in vitro hepatocellular carcinoma model based on human normal and fibrotic 3D extracellular matrix scaffold bio-engineering (2017) (0)
212 SDF-1 ACTS MORE AS A CHEMOTACTIC AGENT THAN AS A SURVIVAL FACTOR ON THE INTERACTION OF HUMAN HEPATIC STELLATE CELLS (HHSC) AND CCA CELL LINES (2011) (0)
Proteomic Analysis of Liver Fibrotic Septa and Periportal Spaces in Primary Sclerosing Cholangitis, Primary Biliary Cholangitis and Alcoholic Liver Disease (2016) (0)
Erratum to: Chapter 9 in Consensus Statements: Session 1—Screening and Surveillance (2016) (0)
PS-209-Whole Human liver decellularisation-recellularisation for future liver transplantation and extracorporeal device application (2019) (0)
Mucosal-associated invariant T cells are significantly decreased and exhausted in patients with autoimmune liver disease, but promote primary hepatic stellate cell proliferation (2017) (0)
Diagnosis and prognosis of patients with liver fibrosis based on clinical and laboratory parameters (2019) (0)
PTU-034 Spleen stiffness by elastPQ point shear wave elastography predicts clinically significant portal hypertension in PBC (2019) (0)
PWE-139 Further Validation of Terminal Peptide of Procollagen Iii (PIIINP) for the Detection and Assessment of Nonalcoholic Steatohepatitis in Patients with Nonalcoholic Fatty Liver Disease (2013) (0)
PTH-126 Azathioprine, steroids and the presence of inflammatory bowel disease before liver transplantation influence transplant free survival in primary sclerosing cholangitis (2015) (0)
PDGF-BB as mitogenic and chemotactic stimulus for bone marrow-derived human mesenchymal stem cells, putative precursors of profibrogenic myofibroblast-like cells (2007) (0)
PS-166-Repopulation of decellularized porcine bile ducts with human cholangiocyte organoids for the generation of human-sized bioengineered biliary tissue (2019) (0)
1131 THE MYOSTATIN SYSTEM IS EXPRESSED IN THE LIVER AND ITS ACTIVATION MEDIATES PROFIBROGENIC ACTIONS IN HEPATIC STELLATE CELLS (HSC) VIA c-Jun N-TERMINAL KINASE (JNK) (2013) (0)
Comparison of point-shear wave elastography (ElastPQ) and fibroscan transient elastography (F-TE) for liver fibrosis staging in patients with NAFLD (2020) (0)
Transcriptomic analysis confirms that PNPLA3 I148M variant is associated with impaired mitochondrial function and antioxidant response in 3D cultured human hepatic stellate cells and liver tissue of patients with NAFLD (2022) (0)
Defective Chromosome Segregation Causes DNA Damage and Chromosome Abnormalities In Human Hepatocellular Carcinoma (2016) (0)
LIVER Dose dependent and divergent effects of superoxide anion on cell death , proliferation , and migration of activated human hepatic stellate cells (2005) (0)
Reply: (2008) (0)
F-30 The receptor CXCR7 contributes to proliferation and migration of hepatic stellate cells (2012) (0)
Hypoxia – induced migration of human hepatic stellate cellsrequires an early and redox sensitive activation of c-Jun N-terminal kinase (2008) (0)
Sa1826 - Serological Assessment of type Xvi Collagen Reflects Intestinal Strictures in Crohns Disease Patients (2018) (0)
The CXCL12/CXCR7 System Mediates Migration and Survival of Cholangiocarcinoma (CCA) Cells through Interaction with CXCR4 and Barrestin-2 (2016) (0)
Chk2 DNA damage response protein mislocalization further enhances chromosomal instability and human hepatocellular carcinoma progression (2017) (0)
Established cirrhosis at the time of diagnosis predicts adverse outcome in autoimmune hepatitis: A retrospective cohort study (2017) (0)
Rapid production of human liver scaffolds for functional tissue engineering by high shear stress oscillation-decellularization (2017) (0)
The Challenge of Drug-Induced Liver Injury (DILI) / Challenges and Management of Liver Cirrhosis: The Challenge of Drug-Induced Liver Injury (DILI) Falk Workshop, Freiburg, October 2014 Challenges and Management of Liver Cirrhosis Falk Symposium 195, Freiburg, October 2014 (2015) (0)
1045 PIRFENIDONE MAINTAINS NUCLEAR NRF2 ACTIVATION AND REDUCES PROINFLAMMATORY AND FIBROGENIC EFFECTS INDUCED BY OXIDATIVE STRESS IN HUMAN HEPATIC STELLATE CELLS (HSC) (2011) (0)
Reply to "Do we need to re-define the Baveno VI elastography criteria for compensated advanced chronic liver disease (cACLD)?" (2021) (0)
REAL TIME 2D SHEAR WAVE ELASTOGRAPHY IN THE ARENA OF ELASTOMETRIC METHODS FOR NON-INVASIVE ASSESMENT OF LIVER DISEASE (2016) (0)
T-55 Functional role of the chemokine receptor CXCR7 on CXCL12-induced chemotaxis and cell survival in cholangiocarcinoma (CCA) cells (2013) (0)
Orthotopic Liver Transplantation Cell Therapy Autologous Cell Therapy larisation larisation Skin biopsy iPSc Ex vivo gene therapy + Cells Hepatocyte Isolation Hepatocyte expansion Synthetic polymer Xenotransplant (2015) (0)
P125 Basement membrane remodelling as a biomarker for monitoring disease activity in Crohn’s disease patients: the role of laminin (2018) (0)
Foreword to liver fibrosis Preface (2011) (0)
SAT-430-Spleen stiffness measured with ElastPQ point shear wave elastography has a good performance in predicting clinically significant portal hypertension in patients with primary sclerosing cholangitis (2019) (0)
Professor Mike Kew and the Royal Free Hospital (2018) (0)
The clinical utility of noninvasive blood tests and elastography (2016) (0)
F-47 The adipokine chemerin as a novel factor regulating the fibrogenic phenotype of human hepatic stellate cells (2011) (0)
O026 : CD4+ intrahepatic lymphocytes drive liver inflammation via impaired regulatory pathways in a murine model of Crohn's-like ileitis (2015) (0)
336 VEGF and angiopoietin-1 as hypoxia-inducible, autocrine and paracrine chemotactic factors for human hepatic stellate cells (2006) (0)
263 In vitro effect of specific somatostatin receptor agonists on human hepatocellular carcinoma (2004) (0)
O06 Aminobisphosphonates enhance liver-resident gamma delta T cells for efficient targeting of hepatocellular carcinoma (2021) (0)
CD81 engagement by HCV envelope protein E2 mediates proMMP-2 synthesis and is associated with PI 4-kinase activation in human hepatic stellate cells (2002) (0)
Growth factor-induced survival pathways in activated human HSC: long-term dynamics and PI 3-K-independednt modulation of BAD phosphorylation (2002) (0)
Faculty Opinions recommendation of CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. (2006) (0)
Mucosa Associated Invariant T Cells are Phenotypically Altered and Functionally Impaired in Patients with Autoimmune Liver Disease (2016) (0)
T-6 Oncostatin M stimulates chemotaxis of human hepatic profibrogenic cells (2011) (0)
Intermittent fever in a patient with apparent fatty liver (2006) (0)
Soluble factors produced by activated human hepatic stellate cells (HSC) promote invasive tumor phenotype and scattering (2003) (0)
Cardiovascular risk factors are independent of fibrosis severity in NAFLD (2017) (0)
ANATOMIC CONSIDERATIONS OF THE NORMAL PORTAL CIRCULATION (2017) (0)
Combined elastin and collagen proportionate area sub-classifies cirrhosis and predicts clinical outcomes (2018) (0)
Interaction between 4-Hydroxy-2,3-alkenals and the Platelet-derived Growth Factor-β Receptor (2000) (0)
Faculty Opinions recommendation of Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. (2007) (0)
The inhibitory effect of ADM on hepatic NF-κB activation in 2D and 3D hepatic cell cultures (2018) (0)
Cholestasis and Fibrogenesis (2020) (0)
Chemotaxis in Profibrogenic Human Hepatic Stellate Cells Requires Redox – Dependent Activation of c-Jun N-Terminal Kinase Isoforms 1 and 2 (2008) (0)
Collagen proportionate area predicts long-term mortality in patients with alcoholic hepatitis. (2021) (0)
106 MYRISTOYLATED ALANINE RICH PROTEIN KINASE C SUBSTRATE (MARCKS), A FUNDAMENTAL CELL CYCLE REGULATOR OF THE MITOTIC PROCESS IN HUMAN HEPATIC STELLATE CELLS (HHSC) (2010) (0)
Albert Geerts One of the “young boys” (2009) (0)
Lecture ‒ Stellate Cells: Do They Have a Role in Portal Hypertension? (2008) (0)
P.09.11 HIGH PREVALENCE OF DEFECTIVE SPLEEN FUNCTION IN AUTOIMMUNE GASTROINTESTINAL AND LIVER DISEASES (2018) (0)
Cardiovascular risk factors and fibrosisseverity in NAFLD: is there a link? (2018) (0)
Inhibition of PDGF-dependent mitogenic signaling in human hepatic stellate cells exposed to pro-oxidant conditions (2001) (0)
HEPATOCELLULAR CARCINOMA DIFFERENTIALLY MODULATES AMPK ACTIVITY AND INDUCES AUTOPHAGY IN HEPATIC STELLATE CELLS IN A PARACRINE MANNER (2016) (0)
Ammonia Produces Pathological Changes And Activation In Human Hepatic Stellate Cells And Is A Target For Therapy In Portal Hypertension (2015) (0)
Curcumin inhibits the fibrogenic progression of murine steatohepatitis (2007) (0)
Silencing of Bcl-2 expression in human hepatic stellate cells turns off their survival attitude (2005) (0)
SAT-397-HIC-5 and GARP expression is upregulated by hydrogen peroxide and TGF beta in primary human hepatic stellate cells cultured on decellularized human liver 3D ECM scaffolds (2019) (0)
P85 CHOLANGIOCARCINOMA (CCA) EXPRESS CHEMOKINE RECEPTOR CXCR7: IMPORTANT ROLE OF CXCR7 IN MEDIATING CXCL12 INDUCED CCA CELLS CHEMOTAXIS AND SURVIVAL (2014) (0)
Clinical evaluation of disease progression in chronic liver disease: towards an integrated system? (2008) (0)
Mixed hepatic iron deposition but not serum ferritin is associated with the presence of nonalcoholic steatohepatitis (NASH) (2018) (0)
Transient elastography (TE) is more effective for the identification of HCV patients with severe (≥F3) rather than significant (≥F2) liver fibrosis (2008) (0)
Reply to "Baveno VI elastography criteria for ruling in cACLD works well in MAFLD patients" and "Transient elastography in chronic liver disease: beware to the cut-offs!" (2021) (0)
Survival and phenotypic responses of fully activated human hepatic stellate cells to superoxide and TNF: critical role of generation rate and Bcl-2 levels (2005) (0)
Hepatology Snapshot: Hepatic regenerative medicine (2015) (0)
Pro-fibrogenic role of alarmin high mobility group box 1 in HIV–hepatitis B virus coinfection (2022) (0)
Relationship between Pattern of Hepatic Iron Deposition, Disease Severity and Clinical Outcomes in Non-Alcoholic Fatty Liver Disease (2016) (0)
OC-4 Myostatin: a novel modulator of hepatic stellate cell biology (2012) (0)
Targeting tumour-stromal interactions – differential pharmacological modification of AMPK/mTORC1 in human hepatic stellate cells and hepatocellular carcinoma (2017) (0)
ReviewMolecular basis and clinical endopoints for the development of antifibrogenic drugs (2010) (0)
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond (2018) (0)
P906 AZATHIOPRINE AND EARLY TACROLIMUS LEVELS <10 ng/mL ARE PROTECTIVE AGAINST PROGRESSIVE FIBROSIS IN RECURRENT HCV POST LT (2014) (0)
[343] PDGF-BB IS AN EFFECTIVE MITOGENIC AND CHEMOTACTIC STIMULUS FOR BONE MARROW-DERIVED HUMAN MESENCHYMAL STEM CELLS, PUTATIVE PRECURSORS OF PROFIBROGENIC MYOFIBROBLAST-LIKE CELLS (2007) (0)
REDOX- AND HIF-1α/VEGF - DEPENDENT MIGRATION OF HUMAN ACTIVATEDHEPATIC STELLATE CELLS EXPOSED TO ONCOSTATIN M (2011) (0)
In Memoriam: Valerio Nobili (1966-2019). (2019) (0)
Differential regulation of monocyte chemoattractant protein-1 (MCP-1) expression in hepatic stellate cells by members of the mitogen-activated protein kinase (MAPK) family (2003) (0)
1034 ONCOSTATIN M STIMULATES DIRECTIONAL MIGRATION OF HUMAN HEPATIC PROFIBROGENIC CELLS (2011) (0)
Occurrence and Clinicopathological Relevance of Prognostic Markers in Hepatocellular Carcinoma (2011) (0)
P287 HEPATIC C6-CERAMIDE NANOLIPOSOMAL UPTAKE AFFECTS MCD-INDUCED NASH IN VIVO VIA ALTERATIONS IN PROLIFERATIVE, FIBROTIC AND OXIDATIVE STRESS SIGNALING PATHWAYS (2014) (0)
355 Beta 3-specific non-peptidic integrin antagonist EMD409915 blocks PDFG-stimulated migration in human hepatic stellate cells but not in foreskin fibroblasts (2003) (0)
P89 HEAT SHOCK FACTOR 1 (HSF1) IS DOWNREGULATED IN RADIOFREQUENCY ABLATED MICE WITH SECONDARY LIVER CANCER PRETREATED WITH NANOLIPOSOMAL shRNA-HSF1 (2014) (0)
318 A secreted form of ADAM9 by liver myofibroblasts promotes tumor invasion through stromal-tumor interactions (2004) (0)
Organization of the lymphoid tissue in livers with chronic active hepatitis. (2000) (0)
324 Differential expression of two isoforms of the chemokine receptor CXCR3 determines the ultimate effect of IP-10 on survival of human hepatic stellate cells (HSC) (2004) (0)
Pro-fibrogenic role of alarmin HMGB1 in HIV-HBV co-infection. (2022) (0)
391 THE CHEMOKINE RECEPTOR CXCR7 CONTRIBUTES TO PROLIFERATION AND MIGRATION OF HEPATIC STELLATE CELLS (2012) (0)
Non-Invasive Assesment of Chronic Liver Disease by Two Dimensional Shear Wave Elastography: An Overview (2018) (0)
P428 5-METHYL-1-PHENYL-2-(1H)-PYRIDONE TREATMENT IMPROVES MARKERS OF HEPATIC FUNCTION AND FIBROSIS IN STEATOSIS INDUCED BY HIGH FAT/CARBOHYDRATE DIET (2014) (0)
A Fragment of Collagen Type VI alpha-3 chain is Elevated in Serum from Patients with Gastrointestinal Disorders (2020) (0)
Modulating Tumor-Stromal Interactions by Targeting Adenosine Monophosphate-Activated Kinase (AMPK) in Human Hepatic Stellate Cells and Hepatocellular Carcinoma (2014) (0)
Luca Valenti Referral pathways for patients with NAFLD based on non-invasive fibrosis tests : diagnostic accuracy and cost analysis (2019) (0)
869 HEPATIC STELLATE CELLS PROMOTE HCC PROGRESSION BY SECRETING LAMININ-5 (2010) (0)
Serum Alanine Aminotransferase Level Alone May Not Accurately Represent Necro-lnflammation in Patients with Acute Hepatitis. Authors' reply (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Massimo Pinzani?

Massimo Pinzani is affiliated with the following schools:

Massimo Pinzani's Academic­Influence.com Rankings

Massimo Pinzani's Degrees

Why Is Massimo Pinzani Influential?

Massimo Pinzani's Published Works

Published Works

What Schools Are Affiliated With Massimo Pinzani?

Massimo Pinzani's AcademicInfluence.com Rankings